Senate faces hemp provision fight in stopgap funding bill
The stopgap funding bill includes a one-month delay of a ban on most hemp-derived THC products. House Freedom Caucus Chairman Andy Harris opposes the provision and may vote against the bill. The Senate previously voted to table an amendment that would strip the delay, but opponents plan to try again.
The one-month reprieve, extending the ban's effective date to Dec. 11, was inserted into the Senate version of the funding bill at the White House's urging. Hemp industry advocates view the delay as a chance to press lawmakers for regulatory alternatives to an outright prohibition. The Senate's 61-32 vote to table an amendment stripping the provision showed bipartisan support for the delay, though opponents signaled they will revisit the issue when the funding measure expires.
Harris, who chairs the House Agriculture Appropriations Subcommittee, has framed the dispute as a federal regulatory failure, arguing that intoxicating hemp products sold in retail settings are effectively unregulated marijuana. His resistance could complicate quick House passage of the stopgap measure when lawmakers return from recess.
This dispute could affect consumers who purchase hemp-derived THC products from retail stores, as well as the businesses that manufacture and sell them. A reinstated ban would remove these products from shelves, potentially pushing users toward unregulated markets or traditional marijuana channels. The outcome may also signal how aggressively Congress will address intoxicating hemp compounds in future legislation, shaping regulatory expectations for an industry that has grown rapidly in a legal gray area.